Incyte Corporation (NASDAQ:INCY) Broker Price Targets For The Coming Week

Cornelia Mascio
Ottobre 21, 2017

WARNING: "Shikiar Asset Management Inc". The Bridger Management Llc holds 368,034 shares with $46.34M value, up from 277,674 last quarter. The stock increased 0.60% or $0.32 on October 20, reaching $53.29. About 4.30M shares traded. Metlife Inc (NYSE:MET) has risen 13.92% since October 21, 2016 and is uptrending. It has underperformed by 2.78% the S&P500.

INCY has been the topic of several research reports. Barclays Capital initiated the shares of INCY in report on Thursday, August 13 with "Overweight" rating. FMR LLC raised its stake in shares of Incyte Corp.by 2.1% in the second quarter.

About 82,872 shares traded.

Incyte Corporation (NASDAQ:INCY) last released its quarterly earnings data on Tuesday, August 1st. It has outperformed by 56.14% the S&P500. Therefore 0 are positive. The stock presently has a consensus rating of "Buy" and an average price target of $144.84. MetLife had 40 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with "Buy". The stock of Metlife Inc (NYSE:MET) has "Buy" rating given on Friday, May 5 by Wells Fargo. The rating was initiated by Credit Suisse with "Outperform" on Wednesday, January 20. The firm earned "Sell" rating on Tuesday, March 7 by National Securities. The firm earned "Overweight" rating on Wednesday, August 2 by Barclays Capital. Incyte Corp now has $23.92 billion valuation. INCY rose 1.37%, plunged -0.52% and sank -7.11% in the week, one month and six months, respectively. The number of shares now owned by investors are 207.74 mln. 772.09 million shares or 1.67% less from 785.23 million shares in 2017Q1 were reported. Centurylink Inv Mgmt holds 5,205 shares. Cubist Systematic Strategies Ltd holds 4,775 shares. California State Teachers Retirement Sys owns 1.76 million shares or 0.21% of their U.S. portfolio. The biopharmaceutical company reported ($0.06) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by ($0.01). Granite Point Cap Mngmt Lp holds 0.39% or 12,500 shares in its portfolio. University Of Notre Dame Du Lac, a Indiana-based fund reported 42,078 shares. Grace & White Inc reported 5,103 shares. Ishares Tr (IDU) was reduced too.

Since April 28, 2017, it had 3 buys, and 8 sales for $4.85 million activity. 500 shares were bought by BIENAIME JEAN JACQUES, worth $65,900. Sectoral Asset Incorporated has 0.3% invested in Incyte Corporation (NASDAQ:INCY). The insider Siegel Eric H. sold 1,820 shares worth $227,009. GRYSKA DAVID W had sold 16,756 shares worth $1.95 million. 8,577 shares were sold by Huber Reid M, worth $1.02M on Friday, May 5.

Investors sentiment decreased to 1.02 in Q2 2017. Its down 0.39, from 1.41 in 2017Q1. It fall, as 57 investors sold INCY shares while 158 reduced holdings. 67 funds opened positions while 153 raised stakes. They were forecasting US$0.08 per share three months ago. Driehaus Cap Mgmt Limited Liability owns 8,722 shares or 0.04% of their United States portfolio. First Advsrs Lp holds 572,165 shares. Moreover, Oakbrook Invests Ltd Liability has 0.11% invested in Incyte Corporation (NASDAQ:INCY). Gardner Lewis Asset Management LP stated it has 0.25% in Incyte Corporation (NASDAQ:INCY). Gabelli reiterated a "buy" rating and set a $174.00 price objective on shares of Incyte Corporation in a report on Wednesday, June 28th. Balyasny Asset Limited Liability Corp owns 209,811 shares for 0.11% of their portfolio. Vanguard Group Inc Inc has invested 0.11% in Incyte Corporation (NASDAQ:INCY). One research analyst has rated the stock with a sell rating, one has issued a hold rating and twenty-one have assigned a buy rating to the company. Therefore 83% are positive. They issued a "buy" rating and a $105.00 price objective for the company. Incyte had 68 analyst reports since August 6, 2015 according to SRatingsIntel. Finally, Cowen and Company reissued an "outperform" rating on shares of Incyte Corp.in a report on Wednesday, October 12th. The company was upgraded on Monday, September 11 by Raymond James. The rating was maintained by Brean Capital with "Buy" on Wednesday, September 2. On average, equities analysts predict that Incyte Corporation will post ($0.81) earnings per share for the current year. As per Tuesday, October 6, the company rating was maintained by Nomura. On Thursday, September 3 the stock rating was maintained by JP Morgan with "Overweight". Oppenheimer maintained Incyte Corporation (NASDAQ:INCY) rating on Monday, November 9. Oppenheimer has "Outperform" rating and $129 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE